课题基金 / 基金详情

ACTG A5030-VALGANCICLOVIR PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS (CMV) VIREMIA

ACTG A5030-VALGANCICLOVIR PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS (CMV) VIREMIA
ACTG A5030-缬更昔洛韦预防巨细胞病毒 (CMV) 病毒血症
批准号：
7200527
负责人：
CONSTANCE ANN BENSON
金额：
$11.89万
依托单位：
UNIVERSITY OF COLORADO DENVER
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
项目状态：
已结题
起止时间：
2005-04-01 至 2006-03-31
来源：
https://reporter.nih.gov/project-details/7200527
关键词：
clinical researchhuman subject

项目成果

CONSTANCE ANN BENSON的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
A Novel Wireless Ingestible Sensor System for Measurement of medication Adherence in HIV Treatment and Prevention
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention
海外基金